Influence of gene polymorphisms in ulcer healing process after superficial venous surgery

Journal of Vascular Surgery

Volumn 44, Issue 3, 2006, Pages 554-562

  Gemmati, Donato ^a   Tognazzo, Silvia ^a   Catozzi, Linda ^a   Federici, Federica ^a   De Palma, Massimiliano ^a   Gianesini, Sergio ^a   Scapoli, Gian L ^a   De Mattei, Monica ^a   Liboni, Alberto ^a   Zamboni, Paolo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FXIII P564L GENE; FXIII V34L GENE; GENE; GENETIC VARIABILITY; GENOTYPE; HFE C282Y GENE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL VEIN; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ULCER HEALING; VEIN SURGERY; WOUND HEALING IMPAIRMENT;

AGED; FACTOR XIII; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VARICOSE ULCER; WOUND HEALING;

EID: 33747885218     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.05.011     Document Type: Article

References (35)

1. Bergqvist D., Lindholm C., and Nelzen O. Chronic leg ulcers. the impact of venous disease. J Vasc Surg 29 (1999) 752-755
2. Abbade L.P., and Lastoria S. Venous ulcer. epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 44 (2005) 449-456
3. Abbade L.P., Lastoria S., de Almeida Rollo H., and Stolf H.O. A sociodemographic, clinical study of patients with venous ulcer. Int J Dermatol 44 (2005) 989-992
4. Cesarone M.R., Belcaro G., Nicolaides A.N., Geroulakos G., Griffin M., Incandela L., et al. 'Real' epidemiology of varicose veins and chronic venous diseases. the San Valentino Vascular Screening Project. Angiology 53 (2002) 119-130
5. Nelzen O. Leg ulcers. economic aspects. Phlebology 15 (2000) 110-114
6. van Geest A.J., Veraart J.C., Nelemans P., and Neumann H.A. The effect of medical elastic compression stockings with different slope values on edema. Measurements underneath three different types of stockings. Dermatol Surg 26 (2000) 244-247
7. De Palma R.G., and Kowallek D.L. Venous ulceration. a cross-over study from nonoperative to operative treatment. J Vasc Surg 24 (1996) 788-792
8. Barwell J.R., Taylor M., Deacon J., Ghauri A.S., Wakely C., Phillips L.K., et al. Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers. Eur J Vasc Endovasc Surg 20 (2000) 363-368
9. Barwell J.R., Davies C.E., Deacon J., Harvey K., Minor J., Sassano A., et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study). randomised controlled trial. Lancet 363 (2004) 1854-1859
10. Tenbrook Jr. J.A., Iafrati M.D., O'Donnell Jr. T.F., Wolf M.P., Hoffman S.N., Pauker S.G., et al. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 39 (2004) 583-589
11. Zamboni P., Cisno C., Marchetti F., Mazza P., Fogato L., Carandina S., et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment. a randomized clinical trial. Eur J Vasc Endovasc Surg 25 (2003) 313-318
12. Gohel M.S., Taylor M., Earnshaw J.J., Heather B.P., Poskitt K.R., and Whyman M.R. Risk factors for delayed healing and recurrence of chronic venous leg ulcers-an analysis of 1324 legs. Eur J Vasc Endovasc Surg 29 (2005) 74-77
13. Margolis D.J., Berlin J.A., and Strom B.L. Risk factors associated with the failure of a venous ulcer to heal. Arch Dermatol 135 (1999) 920-926
14. Zamboni P., Tognazzo S., Izzo M., Pancaldi F., Scapoli G.L., Liboni A., and Gemmati D. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg 42 (2005) 309-314
15. Zamboni P., Izzo M., Tognazzo S., Carandina S., De Palma Massimiliano, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med 40 (2006) 1869-1873
16. Gemmati D., Tognazzo S., Serino M.L., Fogato L., Carandina S., De Palma M., et al. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension. Wound Repair Regen 12 (2004) 512-517
17. Beutler E., Felitti V.J., Koziol J.A., Ho N.J., and Gelbart T. Penetrance of 845G →A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359 (2002) 211-218
18. Inbal A., Lubetsky A., Krapp T., Castel D., Shaish A., Dickneite G., et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 94 (2005) 432-437
19. Bereczky Z., Katona E., and Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb 33 (2004) 430-437 2003-
20. Zamboni P., Marcellino M.G., Cappelli M., Feo C.V., Bresadola V., Vasquez G., et al. Saphenous vein sparing surgery. principles, techniques and results. J Cardiovasc Surg 39 (1998) 151-162
21. Zamboni P., Cisno C., Marchetti F., Quaglio D., Mazza P., and Liboni A. Reflux elimination without any ablation or disconnection of the saphenous vein. A haemodynamic model for venous surgery. Eur J Vasc Endovasc Surg 21 (2001) 361-369
22. Nicolaides A.N. Investigation of chronic venous insufficiency. a consensus statement (France, March 5-9, 1997). Circulation 102 (2000) 126-163
23. Eklof B., Rutherford R.B., Bergan J.J., Carpentier P.H., Gloviczki P., Kistner R.L., et al. Revision of the CEAP classification for chronic venous disorders. consensus statement. J Vasc Surg 40 (2004) 1248-1252
24. Gemmati D., Serino M.L., Ongaro A., Tognazzo S., Moratelli S., Resca R., et al. A common mutation in the gene for coagulation factor XIII-A (Val34Leu). a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67 (2001) 183-188
25. Kohler H.P., Futers T.S., and Grant P.J. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Thromb Haemost 81 (1999) 511-515
26. Milman N., and Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64 (2003) 36-47
27. Ashworth J.J., Smyth J.V., Pendleton N., Horan M., Payton A., Worthington J., et al. The dinucleotide (CA) repeat polymorphism of estrogen receptor beta but not the dinucleotide (TA) repeat polymorphism of estrogen receptor alpha is associated with venous ulceration. J Steroid Biochem Mol Biol 97 (2005) 266-270
28. Nagy N., Szolnoky G., Szabad G., Bata-Csorgo Z., Dobozy A., Kemeny L., et al. Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer. J Invest Dermatol 124 (2005) 1085-1088
29. Wallace H.J., Vandongen Y.K., and Stacey M.C. Tumor necrosis factor-alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol 126 (2006) 921-925
30. Zamboni P., De Mattei M., Ongaro A., Fogato L., Carandina S., De Palma M., et al. Factor XIII contrasts the effects of metallo-proteinases in human dermal fibroblast cultured cells. Vasc Endovascular Surg 38 (2004) 431-438
31. Zamboni P., Scapoli G., Lanzara V., Izzo M., Fortini P., Legnaro R., et al. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg 31 (2005) 644-649
32. Dardik R., Loscalzo J., and Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 4 (2006) 19-25
33. Dardik R., Loscalzo J., Eskaraev R., and Inbal A. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler Thromb Vasc Biol 25 (2005) 526-532
34. Chung S.I., Lee S.Y., Ryogin U., and Kamemitsu K. Affects of F XIII in wound-healing-Fibrin stability in tissues and cross linking of angiogenesis modulator, osteonectin to fibrin. Rinsho Byori Suppl 104 (1997) 50
35. Moura E., Noordermeer M.A., Verhoeven N., Verheul A.F., and Marx J.J. Iron release from human monocytes after erythrophagocytosis in vitro. an investigation in normal subjects and hereditary hemochromatosis patients. Blood 92 (1998) 2511-2519